Because IL6 plays a fundamental role in supporting the systemic host response to tissue injury, the higher levels of IL6 in bladder cancer patients may be the results of a complex systemic immune response mediated by peripheral blood mononuclear cells [31]. The gene discussed is IL6; the disease is urinary bladder cancer.